Philip Joseph

8.7k total citations · 2 hit papers
51 papers, 2.0k citations indexed

About

Philip Joseph is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Philip Joseph has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 11 papers in Economics and Econometrics and 8 papers in Surgery. Recurrent topics in Philip Joseph's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Blood Pressure and Hypertension Studies (8 papers) and Medication Adherence and Compliance (6 papers). Philip Joseph is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Blood Pressure and Hypertension Studies (8 papers) and Medication Adherence and Compliance (6 papers). Philip Joseph collaborates with scholars based in Canada, United Kingdom and India. Philip Joseph's co-authors include Salim Yusuf, Sonia S. Anand, Darryl P. Leong, Koon Teo, Martin McKee, Jon-David Schwalm, Andrew Mente, Guillaume Paré, Michael J. Harrison and Tom Treasure and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Philip Joseph

45 papers receiving 1.9k citations

Hit Papers

Reducing the Global Burden of Cardiovascular Disease, Part 1 2017 2026 2020 2023 2017 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Joseph Canada 20 790 313 301 226 194 51 2.0k
José M. Castellano Spain 24 664 0.8× 309 1.0× 259 0.9× 125 0.6× 153 0.8× 70 1.8k
Sean Murphy United States 15 1.0k 1.3× 299 1.0× 247 0.8× 114 0.5× 151 0.8× 50 2.1k
Sang‐Hyun Ihm South Korea 25 1.3k 1.6× 289 0.9× 302 1.0× 195 0.9× 378 1.9× 157 2.2k
Dénes Páll Hungary 20 959 1.2× 315 1.0× 344 1.1× 336 1.5× 455 2.3× 87 2.2k
Davide Soranna Italy 28 713 0.9× 297 0.9× 427 1.4× 130 0.6× 309 1.6× 99 2.3k
Li Fan China 22 635 0.8× 176 0.6× 231 0.8× 147 0.7× 297 1.5× 120 2.0k
Xingang Zhang China 24 834 1.1× 216 0.7× 170 0.6× 536 2.4× 288 1.5× 91 2.0k
Constantinos Koshiaris United Kingdom 17 653 0.8× 128 0.4× 308 1.0× 178 0.8× 182 0.9× 56 1.7k
Ambuj Roy India 23 1.0k 1.3× 126 0.4× 246 0.8× 247 1.1× 208 1.1× 147 2.1k

Countries citing papers authored by Philip Joseph

Since Specialization
Citations

This map shows the geographic impact of Philip Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Joseph more than expected).

Fields of papers citing papers by Philip Joseph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Joseph. The network helps show where Philip Joseph may publish in the future.

Co-authorship network of co-authors of Philip Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Joseph. A scholar is included among the top collaborators of Philip Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Joseph. Philip Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Watkins, David, David Flood, Thomas A. Gaziano, et al.. (2025). Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050. Journal of the American College of Cardiology. 86(3). 149–161.
3.
Schwalm, Jon-David, Philip Joseph, Darryl P. Leong, et al.. (2025). Cardiovascular disease in the Americas: optimizing primary and secondary prevention of cardiovascular disease. The Lancet Regional Health - Americas. 42. 100964–100964. 3 indexed citations
4.
Joseph, Philip, et al.. (2025). Obesity and BMI score as risk factors for urolithiasis: a systematic review over 30 years. Current Opinion in Urology. 35(4). 338–346. 1 indexed citations
6.
Khetan, Aditya, Lia M. Palileo‐Villanueva, Nafiza Mat Nasir, et al.. (2024). Mortality, Cardiovascular Disease, and Their Associations With Risk Factors in Southeast Asia. JACC Asia. 4(8). 624–633. 1 indexed citations
7.
Walli-Attaei, Marjan, Philip Joseph, Isabelle Johansson, et al.. (2024). Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry. The Lancet Global Health. 12(3). e396–e405. 15 indexed citations
8.
Lamy, André, Philip Joseph, Peggy Gao, et al.. (2024). Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysis. EClinicalMedicine. 73. 102651–102651. 2 indexed citations
9.
Ismail, Rosnah, Noor Hassim Ismail, Zaleha Md Isa, et al.. (2023). Prevalence and Factors Associated with Prehypertension and Hypertension Among Adults: Baseline Findings of PURE Malaysia Cohort Study. SHILAP Revista de lepidopterología. 10. 100049–100049. 5 indexed citations
10.
Leong, Darryl P., Philip Joseph, John J.V. McMurray, et al.. (2023). Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. European Heart Journal. 44(42). 4435–4444. 22 indexed citations
11.
Sepanlou, Sadaf G, Johannes F.E. Mann, Philip Joseph, et al.. (2023). Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD. Clinical Journal of the American Society of Nephrology. 18(11). 1408–1415. 7 indexed citations
12.
Joseph, Philip, et al.. (2020). The Impact of Palliative Care on Clinical and Patient-Centred Outcomes in Patients with Advanced Heart Failure: A Systematic Review of Randomized Controlled Trials. European Journal of Heart Failure. 22(12). 2340–2346. 54 indexed citations
13.
Leong, Darryl P., John J.V. McMurray, Philip Joseph, & Salim Yusuf. (2019). From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5). Journal of the American College of Cardiology. 74(5). 683–698. 28 indexed citations
14.
Joseph, Philip, Karl Swedberg, Darryl P. Leong, & Salim Yusuf. (2019). The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5). Journal of the American College of Cardiology. 74(5). 672–682. 51 indexed citations
15.
Joseph, Philip, Prem Pais, Antonio L Dans, et al.. (2018). The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct. American Heart Journal. 206. 72–79. 22 indexed citations
16.
Joseph, Philip, Guillaume Paré, Senay Asma, et al.. (2016). Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations. Canadian Journal of Cardiology. 32(12). 1440–1446. 18 indexed citations
17.
Sohani, Zahra, David Meyre, Russell J. de Souza, et al.. (2015). Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genetics. 16(1). 50–50. 125 indexed citations
18.
Joseph, Philip, Guillaume Paré, Stuart J. Connolly, et al.. (2013). EFFECT OF DABIGATRAN ON SERUM APOLIPOPROTEIN B AND APOLIPOPROTEIN A1 CONCENTRATIONS. Journal of the American College of Cardiology. 61(10). E300–E300. 2 indexed citations
19.
Yusuf, Salim, Amir Attaran, Jackie Bosch, et al.. (2013). Combination Pharmacotherapy to Prevent Cardiovascular Disease: Present Status and Challenges. SSRN Electronic Journal. 18 indexed citations
20.
Joseph, Philip & Koon Teo. (2011). Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease. Current Cardiology Reports. 13(4). 287–295. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026